REQUEST A DEMO
Total
USD $0.00
Search more companies

Dajpharm S.A.S. (Ecuador)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Secondary Activities: Pharmaceutical and Medicine Manufacturing | Miscellaneous Nondurable Goods Merchant Wholesalers | Pharmacies and Drug Stores | Offices of Physicians | Medical and Diagnostic Laboratories | Other Ambulatory Health Care Services
Full name: Dajpharm S.A.S. Profile Updated: September 08, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Spanish Download a sample report

Dajpharm S.A.S. is a company in Ecuador, with a head office in Quito. The enterprise currently operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. It was established on April 26, 2023. There are currently 3 (2024) people employed by Dajpharm S.A.S.. From the latest financial highlights, Dajpharm S.A.S. reported a net sales revenue increase of 2082.14% in 2024. Its total assets grew by 505.28% over the same period. In, 2024, the company’s net profit margin increased by 3.24%.

Headquarters
Calle Las Alondras, 200
Quito; Pichincha;

Contact Details: Purchase the Dajpharm S.A.S. report to view the information.

Basic Information
Total Employees:
Purchase the Dajpharm S.A.S. report to view the information.
Registered Capital:
Purchase the Dajpharm S.A.S. report to view the information.
Financial Auditors:
Purchase the Dajpharm S.A.S. report to view the information.
Incorporation Date:
April 26, 2023
Key Executives
Purchase this report to view the information.
President
Ownership Details
Purchase this report to view the information.
70%
Purchase this report to view the information.
10%
Purchase this report to view the information.
10%
Purchase this report to view the information.
10%
Company Performance
Financial values in the chart are available after Dajpharm S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
2082.14%
Total operating revenue
2084.79%
Operating profit (EBIT)
10686.6%
EBITDA
10686.6%
Net Profit (Loss) for the Period
58724.92%
Total assets
505.28%
Total equity
358.85%
Operating Profit Margin (ROS)
5.26%
Net Profit Margin
3.24%
Return on Equity (ROE)
77.63%
Debt to Equity Ratio
-117.32%
Quick Ratio
0.04%
Cash Ratio
-0.05%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?